Institut Pasteur Preclinical Study: Ivermectin a Powerful Immunomodulatory Drug Targeting SARS-CoV-2

A prestigious global research institute based in France has published a preclinical study in EMBO Molecular Medicine revealing that ivermectin is associated with a reduction … Continue reading Institut Pasteur Preclinical Study: Ivermectin a Powerful Immunomodulatory Drug Targeting SARS-CoV-2